Zhong Chen1, Yi-Tao Ding. 1. Department of General Surgery, Affiliated Hospital, Nantong University, Nantong 226001, Jiangsu Province, China. chenz_surg@sina.com.cn
Abstract
AIM: To evaluate the functions of a new bioartificial liver (BAL) system in vitro and in vitro. METHODS: The BAL system was configured by inoculating porcine hepatocyte spheroids into the cell circuit of a hollow fiber bioreactor. In the experiments of BAL in vitro, the levels of alanine aminotransferase (ALT), total bilirubin (TB), and albumin (ALB) in the circulating hepatocyte suspension and RPMI-1640 medium were determined during 6 h of circulation in the BAL device. In the experiments of BAL in vitro, acute liver failure (ALF) model in canine was induced by an end-side portocaval shunt combined with common bile duct ligation and transaction. Blood ALT, TB and ammonia levels of ALF in canines were determined before and after BAL treatment. RESULTS: During 6 h of circulation in vitro, there was no significant change of ALT, whereas the TB and ALB levels gradually increased with time both in the hepatocyte suspension and in RPMI-1640 medium. In the BAL treatment group, blood ALT, TB and ammonia levels of ALF in canines decreased significantly. CONCLUSION: The new BAL system has the ability to perform liver functions and can be used to treat ALF.
AIM: To evaluate the functions of a new bioartificial liver (BAL) system in vitro and in vitro. METHODS: The BAL system was configured by inoculating porcine hepatocyte spheroids into the cell circuit of a hollow fiber bioreactor. In the experiments of BAL in vitro, the levels of alanine aminotransferase (ALT), total bilirubin (TB), and albumin (ALB) in the circulating hepatocyte suspension and RPMI-1640 medium were determined during 6 h of circulation in the BAL device. In the experiments of BAL in vitro, acute liver failure (ALF) model in canine was induced by an end-side portocaval shunt combined with common bile duct ligation and transaction. Blood ALT, TB and ammonia levels of ALF in canines were determined before and after BAL treatment. RESULTS: During 6 h of circulation in vitro, there was no significant change of ALT, whereas the TB and ALB levels gradually increased with time both in the hepatocyte suspension and in RPMI-1640 medium. In the BAL treatment group, blood ALT, TB and ammonia levels of ALF in canines decreased significantly. CONCLUSION: The new BAL system has the ability to perform liver functions and can be used to treat ALF.
Authors: Scott L Nyberg; Joseph Hardin; Bruce Amiot; Upendra A Argikar; Rory P Remmel; Piero Rinaldo Journal: Liver Transpl Date: 2005-08 Impact factor: 5.799
Authors: N Koide; K Sakaguchi; Y Koide; K Asano; M Kawaguchi; H Matsushima; T Takenami; T Shinji; M Mori; T Tsuji Journal: Exp Cell Res Date: 1990-02 Impact factor: 3.905
Authors: K Naruse; Y Sakai; G Lei; Y Sakamoto; T Kobayashi; C Puliatti; G Aronica; W Morale; F Leone; S Qiang; S G Ming; S Ming; Z Li; S J Chang; M Suzuki; M Makuuchi Journal: Artif Organs Date: 2001-04 Impact factor: 3.094
Authors: Achilles A Demetriou; Robert S Brown; Ronald W Busuttil; Jeffrey Fair; Brendan M McGuire; Philip Rosenthal; Jan Schulte Am Esch; Jan Lerut; Scott L Nyberg; Mauro Salizzoni; Elizabeth A Fagan; Bernard de Hemptinne; Christoph E Broelsch; Maurizio Muraca; Joan Manuel Salmeron; John M Rabkin; Herold J Metselaar; Daniel Pratt; Manuel De La Mata; Lawrence P McChesney; Gregory T Everson; Philip T Lavin; Anthony C Stevens; Zorina Pitkin; Barry A Solomon Journal: Ann Surg Date: 2004-05 Impact factor: 12.969
Authors: Nils R Frühauf; Karl J Oldhafer; Maike Höltje; Gernot M Kaiser; Jan-Henning Frühauf; Gregor A Stavrou; Augustinus Bader; Christoph E Broelsch Journal: Surgery Date: 2004-07 Impact factor: 3.982
Authors: Lei Cai; Jun Weng; Lei Feng; Guolin He; Jiasheng Qin; Zhi Zhang; Yang Li; Qing Peng; Zesheng Jiang; Mingxin Pan; Yi Gao Journal: Biomed Res Int Date: 2016-12-21 Impact factor: 3.411
Authors: Lei Feng; Lei Cai; Guo-Lin He; Jun Weng; Yang Li; Ming-Xin Pan; Ze-Sheng Jiang; Qing Peng; Yi Gao Journal: World J Gastroenterol Date: 2017-11-14 Impact factor: 5.742